Nevertheless, the sets exhibit less structural similarity according to the selected fingerprints. The calculated structural diversity is expected for a de novo design. In this case, it could also be influenced by the initial diversity of the training set. This is encouraging due to the probability that the desired bioactivity could also be transferred to the novel molecules.